Convergence of CRISPR and Stem Cells is Changing Regenerative Medicine | Cure8bio CEO, Faizzan Ahmad

Longevity for Investors with Dr. Greg Bailey and Jess Larsen

Join Dr. Faizzan Ahmad, CEO of Cure8bio, as he explores the frontier of regenerative medicine. From his journey at Oxford to pioneering a hub-and-spoke biotech model, Dr. Ahmad discusses the latest advancements in stem cell therapies, gene editing, and their potential to cure previously untreatable diseases. Learn how these innovations are reshaping the future of healthcare and longevity.

若要收聽兒少不宜的單集,請登入帳號。

隨時掌握此節目最新消息

登入或註冊後,即可追蹤節目、儲存單集和掌握最新資訊。

選取國家或地區

非洲、中東和印度

亞太地區

歐洲

拉丁美洲與加勒比海地區

美國與加拿大